Correlates of Insulin Injection Omission

Peyrot, Mark, Rubin, Richard R., Kruger, Davida F., Travis, Luther B.·2010·Diabetes Care

DOI 10.2337/dc09-1348

Cited by (405)

Items 101–200 of 405

Measuring insulin adherence among adults with type 2 diabetes
Chandra Y. Osborn, J. S. Gonzalez · 2016 · Journal of Behavioral Medicine
Cultural Differences and Considerations When Initiating Insulin
Julio A. Rebolledo, Regina Arellano · 2016 · Diabetes Spectrum
The role of insulin pump therapy for type 2 diabetes mellitus
Zohar Landau, Itamar Raz, Julio Wainstein, Yosefa Bar‐Dayan, Avivit Cahn · 2016 · Diabetes/Metabolism Research and Reviews
Real-world outcomes of initiating insulin glargine-based treatment versus premixed analog insulins among US patients with type 2 diabetes failing oral antidiabetic drugs
Onur Başer, Krishna Tangirala, Wenhui Wei, Lin Xie · 2013 · ClinicoEconomics and Outcomes Research
Insulin degludec improves health‐related quality of life (SF‐36®) compared with insulin glargine in people with Type 2 diabetes starting on basal insulin: a meta‐analysis of phase 3a trials
Nick Freemantle, Luigi Meneghini, T Christensen, Michael Lyng Wolden, JOHAN H. JENDLE, Robert E. Ratner · 2012 · Diabetic Medicine
Insulin Degludec Aspart: The First Co-formulation of Insulin Analogues
Sanjay Kalra · 2014 · Diabetes Therapy
Improved health status with insulin degludec compared with insulin glargine in people with Type 1 diabetes
Philip Home, Luigi Meneghini, Ulrich Wendisch, Robert E. Ratner, Thue Johansen, T Christensen, JOHAN H. JENDLE, A. P. Roberts, Kåre I. Birkeland · 2011 · Diabetic Medicine
When basal insulin is not enough: A dose–response relationship between insulin glargine 100 units/mL and glycaemic control
Guillermo E. Umpierrez, NEIL SKOLNIK, TERRY A. DEX, Louise Traylor, Jason Chao, Charles F. Shaefer · 2019 · Diabetes Obesity and Metabolism
The strawberry-derived permeation enhancer pelargonidin enables oral protein delivery
Nicholas G. Lamson, Katherine C. Fein, John P. Gleeson, Alexandra N. Newby, Sijie Xian, Kyle Cochran, Namit Chaudhary, Jilian R. Melamed, Rebecca L. Ball, Kanika Suri et al. · 2022 · Proceedings of the National Academy of Sciences
Premixed vs basal-bolus insulin regimen in Type 2 diabetes: comparison of clinical outcomes from randomized controlled trials and real-world data
Uchenna Anyanwagu, Jil Mamza, Jason P. Gordon, Richard Donnelly, ISKANDAR RAUF IDRIS · 2017 · Diabetic Medicine
Smart Pen Exposes Missed Basal Insulin Injections and Reveals the Impact on Glycemic Control in Adults With Type 1 Diabetes
Ekberg, Neda Rajamand, Hartvig, Niels Væver, Kaas, Anne, Møller, Jonas Bech, Adolfsson, Peter · 2024 · Journal of Diabetes Science and Technology
Impact of patients’ beliefs about insulin on acceptance and adherence to insulin therapy: a qualitative study in primary care
Liu, Changwei, De Roza, Jacqueline, Ooi, Chai Wah, Mathew, Blessy Koottappal, Elya, Tang, Wern Ee · 2022 · BMC Primary Care
Systematic investigation of fabrication conditions of nanocarrier based on carboxymethyl chitosan for sustained release of insulin
Xiaoyu Bai, Ming Kong, Guixue Xia, Shichao Bi, Zhongzheng Zhou, Chao Feng, Xiaojie Cheng, Xiguang Chen · 2017 · International Journal of Biological Macromolecules
A review of the new GLP-1 receptor agonist/basal insulin fixed-ratio combination products
Wesley A. Nuffer, Ashley Guesnier, Jennifer M. Trujillo · 2018 · Therapeutic Advances in Endocrinology and Metabolism
Patient-reported adherence to insulin regimen is associated with glycemic control among Japanese patients with type 2 diabetes: Diabetes Distress and Care Registry at Tenri (DDCRT 3)
Tsuyoshi Mashitani, Yasuaki Hayashino, Shintaro Okamura, Masako Kitatani, Miyuki Furuya, Satoshi Matsunaga, Hirohito Kuwata, Satoru Tsujii, Hitoshi Ishii · 2013 · Diabetes Research and Clinical Practice
Long-term effectiveness and safety of quadruple combination therapy with empagliflozin versus dapagliflozin in patients with type 2 diabetes: 3-year prospective observational study
Eu Jeong Ku, Dong‐Hwa Lee, Hyun Jeong Jeon, Tae Keun Oh · 2021 · Diabetes Research and Clinical Practice
Which Aspect of Patient–Provider Relationship Affects Acceptance and Adherence of Insulin Therapy in Type 2 Diabetes Mellitus? A Qualitative Study in Primary Care
Blessy Koottappal Mathew, Jacqueline Giovanna De Roza, Changwei Liu, Ling Jia Goh, Chai Wah Ooi, Elya Chen, Shixuan Poon, Wern Ee Tang · 2022 · Diabetes Metabolic Syndrome and Obesity
Adherence to Basal Insulin Therapy Among People with Type 2 Diabetes: A Retrospective Cohort Study of Costs and Patient Outcomes
Magaly Perez‐Nieves, Kristina Secnik Boye, Jacek I. Kiljanski, Dachung Cao, Maureen J. Lage · 2018 · Diabetes Therapy
Adherence to insulin treatment in diabetes: can it be improved?糖尿病患者使用胰岛素治疗的依从性：它能够得到改善吗？
Doggrell, Sheila Anne, Chan, Vincent · 2015 · Journal of Diabetes
Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes
Roberto Trevisan, Matteo Conti, Stefano Ciardullo · 2024 · Diabetologia
Diabetes treatment-related quality of life is associated with levels of self-care activities in insulin injection among Japanese patients with type 2 diabetes: Diabetes Distress and Care Registry at Tenri (DDCRT 8)
Tsuyoshi Mashitani, Yasuaki Hayashino, Shintaro Okamura, Masako Kitatani, Miyuki Furuya, Tadao Iburi, Hirohito Kuwata, Satoru Tsujii, Hitoshi Ishii · 2015 · Acta Diabetologica
Adherence of people with type 2 diabetes mellitus to drug treatment
Lílian Cristiane Gomes, Maria Cristina Foss‐Freitas, Ana Emília Pace · 2014 · Revista Brasileira de Enfermagem
The relationships among fear of hypoglycaemia, diabetes-related quality of life and psychological well-being in Norwegian adults with Type 1 diabetes
Ragnhild B. Strandberg, Marit Graue, Tore Wentzel‐Larsen, Mark F. Peyrot, Astrid Klopstad Wahl, Berit Rokne · 2016 · Diabetes Research and Clinical Practice
The effect of an education programme ( MEDIAS 2 BSC ) of non‐intensive insulin treatment regimens for people with Type 2 diabetes: a randomized, multi‐centre trial
N. Hermanns, Dominic Ehrmann, Sabine Schall, B. Maier, T Haak, Bernhard Kulzer · 2017 · Diabetic Medicine
Treatment beliefs, health behaviors and their association with treatment outcome in type 2 diabetes
Lill‐Brith von Arx, Helge Gydesen, Soren Eik Skovlund · 2016 · BMJ Open Diabetes Research & Care
Treatment intensification with insulin pumps and other technologies in patients with type 2 diabetes: results of a physician survey in the United States
Grunberger, George, Sze, David, Ermakova, Anastasia, Sieradzan, Ray, Oliveria, Teresa, Miller, Eden M. · 2020 · Clinical Diabetes
Perceived medication benefits and their association with interest in using inhaled insulin in type 2 diabetes: a model of patients' cognitive framework
Mark F. Peyrot, Richard R. Rubin · 2011 · Patient Preference and Adherence
A 16-Week Open-Label, Multicenter Pilot Study Assessing Insulin Pump Therapy in Patients with Type 2 Diabetes Suboptimally Controlled with Multiple Daily Injections
Juan P. Frías, Bruce W. Bode, Timothy Silleck Bailey, Mark S. Kipnes, Rocco L. Brunelle, Steven V. Edelman · 2011 · Journal of Diabetes Science and Technology
Association of comorbid and metabolic factors with optimal control of type 2 diabetes mellitus
Satyajeet Roy, Anthony Sherman, MaryJoan Monari-Sparks, Olga Schweiker, Navjot Jain, Etty Sims, Michelle Breda, GitaP Byraiah, Ryan Belecanech, M.C. Coletta et al. · 2016 · North American Journal of Medical Sciences
An indirect treatment comparison of the efficacy of insulin degludec/liraglutide (IDegLira) and insulin glargine/lixisenatide (iGlarLixi) in patients with type 2 diabetes uncontrolled on basal insulin
Marc Evans, Liana K. Billings, Jonas Håkan‐Bloch, Ulla Slothuus, Trine Julie Abrahamsen, Andreas Andersen, Jeroen Paul Jansen · 2017 · Journal of Medical Economics
Risk of Microvascular Complications and Macrovascular Risk Factors in Early-Onset Type 1 Diabetes after at Least 10 Years Duration: An Analysis of Three Population-Based Cross-Sectional Surveys in Germany between 2009 and 2016
Thaddäus Tönnies, Anna Stahl‐Pehe, Christina Bächle, Katty Castillo, Oliver Kuß, Rhuphine Yossa, Lena M E Lindner, Reinhard Walter Holl, Joachim Rosenbauer · 2018 · International Journal of Endocrinology
Exploring the Burden of Mealtime Insulin Dosing in Adults and Children With Type 1 Diabetes
Wendy S. Lane, Emma Lambert, Jesso George, Naveen Rathor, Nandu K S Thalange · 2021 · Clinical Diabetes
Timing of Insulin Injections, Adherence, and Glycemic Control in a Multinational Sample of People with Type 2 Diabetes: A Cross-Sectional Analysis
Schaper, Nicolaas C., Nikolajsen, Annie, Sandberg, Anna, Buchs, Sarah, Bøgelund, Mette · 2017 · Diabetes Therapy
Adherence to insulin therapy and associated factors among patients with diabetes mellitus in public hospitals of Central Zone of Tigray, Ethiopia, 2018: a cross-sectional study
Teklewoini Mariye, Alem Girmay, Tsiyon Birhanu Wube, Hagos Tasew Atalay, Girmay Teklay, Zeray Baraki, Hadgu Gerensea, Tewolde Teklu, Gebrewahed Bezabeh · 2019 · Pan African Medical Journal
Hypoglycemic effect of an extract from date seeds on diabetic rats.
Ahmed F El Fouhil, Aly M Ahmed, Hasem H. Darwish · 2010 · Saudi Medical Journal
Strategies for Insulin Injection Therapy in Diabetes Self-Management
Linda S. Siminerio, Karmeen D. Kulkarni, Jerry D. Meece, Plaza Pharmacy, Frank Lavernia, Deerfield Beach · 2011
Use of V-Go® Insulin Delivery Device in Patients with Sub-optimally Controlled Diabetes Mellitus: A Retrospective Analysis from a Large Specialized Diabetes System
Rosemarie Lajara, Dianne A. Fetchick, Tracy L. Morris, CARLA C. NIKKEL · 2015 · Diabetes Therapy
Identifying and addressing barriers to insulin acceptance and adherence in patients with type 2 diabetes mellitus.
Allison M Petznick · 2013 · PubMed
Further investigation of the psychometric properties of the insulin treatment appraisal scale among insulin-using and non-insulin-using adults with type 2 diabetes: results from diabetes MILES – Australia
Elizabeth Holmes‐Truscott, Frans Pouwer, Jane Speight · 2014 · Health and Quality of Life Outcomes
Clinical and Cost-Effectiveness of Insulin Delivery with V-GO® Disposable Insulin Delivery Device Versus Multiple Daily Injections in Patients with Type 2 Diabetes Inadequately Controlled on Basal Insulin
Rosemarie Lajara, Jaime A. Davidson, CARLA C. NIKKEL, Tracy L. Morris · 2016 · Endocrine Practice
Pramlintide Improved Measures of Glycemic Control and Body Weight in Patients With Type I Diabetes Mellitus Undergoing Continuous Subcutaneous Insulin Infusion Therapy
Kathrin Herrmann, Juan P. Frías, Steven V. Edelman, Karen Lutz, Kevin Shan, Steven Chen, David G. Maggs, Orville Kolterman · 2013 · Postgraduate Medicine
Flexibly timed once‐daily dosing with degludec: a new ultra‐long‐acting basal insulin
Josse, R. G., Woo, V. · 2013 · Diabetes, Obesity and Metabolism
Dealing with the devil: weight loss concerns in young adult women with type 1 diabetes
Myles Balfe, Frank Doyle, Diarmuid Smith, Séamus Sreenan, Ronán Michael Conroy, Ruairı́ Brugha · 2013 · Journal of Clinical Nursing
Initial injectable therapy in type 2 diabetes: Key considerations when choosing between glucagon-like peptide 1 receptor agonists and insulin
Anastasia‐Stefania Alexopoulos, John B. Buse · 2019 · Metabolism
An integrative review on facilitators and barriers in delivering and managing injectable therapies in chronic conditions: A part of the ACNAP project ‘injectable medicines among patients with cardiovascular conditions’
Ekaterini Lambrinou, Martha Kyriakou, Ioanna Lakatamitou, Neil J. Angus, Rani Khatib, Ercole Vellone, Abigail Barrowcliff, Tina Birgitte Hansen, Geraldine Lee · 2020 · European Journal of Cardiovascular Nursing
An extract from date seeds stimulates endogenous insulin secretion in streptozotocin-induced type I diabetic rats
Ahmed F El Fouhil, Aly M Ahmed, Muhammad Atteya, Raeesa A Mohamed, Amr Soliman Moustafa, Hasem H. Darwish · 2013 · Functional Foods in Health and Disease
Self-assembled block copolymer biomaterials for oral delivery of protein therapeutics
Fabiola Anahi Chapa-Villarreal, Matthew Miller, J Jesus Rodriguez‐Cruz, Diego Pérez-Carlos, Nicholas A. Peppas · 2023 · Biomaterials
The need for better insulin therapy
G. Grunberger · 2013 · Diabetes, obesity and metabolism
The impact of insulin therapy and attitudes towards insulin intensification among adults with type 2 diabetes: A qualitative study
Elizabeth Holmes‐Truscott, Jessica L. Browne, Jane Speight · 2016 · Journal of Diabetes and its Complications
Impact of Treatments on Diabetic Control and Gastrointestinal Symptoms After Total Pancreatectomy
Maarten R. Struyvenberg, Zhi Ven Fong, Camilia Rivera Martin, Jennifer F. Tseng, Thomas E. Clancy, Carlos F. Fernandez-del Castillo, Hanna Tillman, Melena D. Bellin, Steven D. Freedman · 2017 · Pancreas
Glucose-lowering therapies, adequacy of metabolic control, and their relationship with comorbid depression in outpatients with type 2 diabetes in a tertiary hospital in Kenya
Fredrick C. F. Otieno, Joseph Edwin Kanu, E M Karari, Violet Okech, Mark David Joshi, Kenn Mutai · 2017 · Diabetes Metabolic Syndrome and Obesity
Comparison of a Novel Insulin Bolus-Patch with Pen/Syringe Injection to Deliver Mealtime Insulin for Efficacy, Preference, and Quality of Life in Adults with Diabetes: A Randomized, Crossover, Multicenter Study
Nancy J.V. Bohannon, Richard M. Bergenstal, Robert M Cuddihy, Davida F. Kruger, Susan List, Elaine M. Massaro, Mark E. Molitch, Philip Raskin, Heather Remtema, Suzanne M. Strowig et al. · 2011 · Diabetes Technology & Therapeutics
Technosphere insulin: inhaled prandial insulin
Tracy Lynn Setji, Beatrice D. Hong, Mark N. Feinglos · 2015 · Expert Opinion on Biological Therapy
Clinical Benefits Over Time Associated with Use of V-Go Wearable Insulin Delivery Device in Adult Patients with Diabetes: A Retrospective Analysis
DAVID R. SUTTON, Charissa Higdon, CARLA C. NIKKEL, Karrie A. Hilsinger · 2018 · Advances in Therapy
Considerations for Diabetes
Robert M Cuddihy, Sarah K. Borgman · 2011 · American Journal of Therapeutics
Correlates of basal insulin persistence among insulin-naïve people with type 2 diabetes: results from a multinational survey
Mark F. Peyrot, Magaly Perez‐Nieves, Jasmina I. Ivanova, Dachuang Cao, Luke M. Schmerold, Samaneh Kalirai, Irene Hadjiyianni · 2017 · Current Medical Research and Opinion
Use of Insulin Degludec/Insulin Aspart in the Management of Diabetes Mellitus: Expert Panel Recommendations on Appropriate Practice Patterns
Tevfik Demir, Serap Turan, Kürşad Ünlühızarcı, Oya Topaloğlu, Tufan Tükek, Dilek Gogaş Yavuz · 2021 · Frontiers in Endocrinology
Improved patient‐reported outcomes with iGlarLixi versus premix BIAsp 30 in people with type 2 diabetes in the SoliMix trial
William H. Polonsky, Francesco Giorgino, Julio Rosenstock, Katherine Whitmire, Elisheva Lew, Mathieu Coudert, Agustina Alvarez, Charlie J. Nicholls, Rory J. McCrimmon · 2022 · Diabetes Obesity and Metabolism
Factors Associated with Persistence and Resumption of Insulin Pen Use for Patients with Type 2 Diabetes
Mark F. Peyrot, Richard R. Rubin · 2010 · Diabetes Technology & Therapeutics
Safety and effectiveness of biphasic insulin aspart 30 in people with type 2 diabetes switching from basal-bolus insulin regimens in the A1chieve study
Guillermo Dieuzeide, Lee‐Ming Chuang, Abdulrahman M. Almaghamsi, Alexey V. Zilov, Jian-Wen Chen, Fernando Javier Lavalle-Gonzalez · 2013 · Primary care diabetes
Attitudes of patients and physicians to insulin therapy in Japan: an analysis of the Global Attitude of Patients and Physicians in Insulin Therapy study
Shin‐ichi Harashima, Akiko Nishimura, Nobuya Inagaki · 2016 · Expert Opinion on Pharmacotherapy
An extract from date seeds having a hypoglycemic effect. Is it safe to use?
Ahmed F El Fouhil, Aly M Ahmed, Hasem H. Darwish, Muhammad Atteya, Ali H Al-Roalle · 2011 · PubMed
The experiences of insulin use among older people with Type 2 diabetes mellitus: A thematic synthesis
Chaya Langerman, Angus Forbes, Glenn Robert · 2022 · Primary care diabetes
Evaluation of preference for a novel durable insulin pen with memory function among patients with diabetes and health care professionals
Kristian Handberg Mikkelsen, Klausmann, Hramiak, Qvist, Xiaohui Guo · 2013 · Patient Preference and Adherence
An additional bolus of rapid-acting insulin to normalise postprandial cardiovascular risk factors following a high-carbohydrate high-fat meal in patients with type 1 diabetes: A randomised controlled trial
Matthew D. Campbell, Mark Walker, Ramzi Ajjan, Karen M. Birch, Javier Thomas Gonzalez, Daniel J. West · 2017 · Diabetes and Vascular Disease Research
SGLT-2 Inhibitors: Is There a Role in Type 1 Diabetes Mellitus Management?
Nabila Ahmed‐Sarwar, Angela K. Nagel, Samantha Leistman, Kevin Heacock · 2017 · Annals of Pharmacotherapy
Simplification of complex insulin regimens using canagliflozin or liraglutide in patients with well‐controlled type 2 diabetes: A 24‐week randomized controlled trial
Yasuyo Ando, Fumika Shigiyama, Takahisa Hirose, Naoki Kumashiro · 2021 · Journal of Diabetes Investigation
Audit of insulin prescription patterns and associated burden among diabetics in a tertiary health institution in Nigeria
Michael Adeyemi Olamoyegun, A. T. Akinlade, Oluwabukola A Ala · 2018 · African Health Sciences
Insulin Administration and the Impacts of Forgetting a Dose
Meryl I. Brod, Betsy Pohlman, Jens Harald Kongsø · 2013 · Patient
Usability and preference assessment of a new prefilled insulin pen versus vial and syringe in people with diabetes, physicians and nurses
Carlos Campos, Rosemarie Lajara, Tony DeLuzio · 2012 · Expert Opinion on Pharmacotherapy
Insulin Degludec 200 Units/mL Is Associated With Lower Injection Frequency and Improved Patient-Reported Outcomes Compared With Insulin Glargine 100 Units/mL in Patients With Type 2 Diabetes Requiring High-Dose Insulin
Mark Warren, LOUIS B. CHAYKIN, Serge A Jabbour, Mae Sheikh‐Ali, Charlotte Thim Hansen, Thor Schütt Svane Nielsen, Paul C. Norwood · 2017 · Clinical Diabetes
Patient-reported Outcomes in Patients with Type 2 Diabetes Treated with Dulaglutide Added to Titrated Insulin Glargine (AWARD-9)
Maria B. Yu, Kate Van Brunt, Zvonko Miličević, Oralee J. Varnado, Kristina Secnik Boye · 2017 · Clinical Therapeutics
A review of sotagliflozin for use in type 1 diabetes
Wesley Nuffer, Briana Williams, Jennifer M. Trujillo · 2019 · Therapeutic Advances in Endocrinology and Metabolism
Medication usage, treatment intensification, and medical cost in patients with type 2 diabetes: a retrospective database study
Machaon Bonafede, Arthi Chandran, Stefan DiMario, Rita Saltiel-Berzin, Drilon Saliu · 2016 · BMJ Open Diabetes Research & Care
Patient Perceptions and Preferences for a Mealtime Insulin Delivery Patch
Mark F. Peyrot, Darlene M. Dreon, Vivien Zraick, Brett Cross, Meng Hee Tan · 2018 · Diabetes Therapy
Clinical and Economic Outcomes of Patients with Type 2 Diabetes on Multiple Daily Injections of Basal-bolus Insulin (MDI) Therapy: A Retrospective Cohort Study
Diana I Brixner, Anastasia Ermakova, Yan Xiong, Ray Sieradzan, Naomi C. Sacks, Philip L. Cyr, Stephanie Taylor · 2019 · Clinical Therapeutics
IDegLira improves patient‐reported outcomes while using a simple regimen with fewer injections and dose adjustments compared with basal–bolus therapy
Eden M Miller, Ankur Doshi, Randi Grøn, Esteban Jódar, Petra Örsy, Mattis Flyvholm Ranthe, Danny H. Sugimoto, Nikolaοs Tentolouris, Adie Viljoen, Liana K. Billings · 2019 · Diabetes Obesity and Metabolism
Simplification of complex insulin therapy: a story of dogma and therapeutic resignation
Dario Giugliano, Lorenzo Scappaticcio, Miriam Longo, Paola Caruso, Maria Ida Maiorino, Giuseppe Bellastella, Katherine Esposito · 2021 · Diabetes Research and Clinical Practice
Making Insulin Accessible: Does Inhaled Insulin Fill an Unmet Need?
Janet B. McGill, David T. Ahn, Steven V. Edelman, C. Rachel Kilpatrick, Tricia Santos Cavaiola · 2016 · Advances in Therapy
Improved glycaemic control and treatment satisfaction with a simple wearable 3‐day insulin delivery device among people with Type 2 diabetes
Julia Katharina Mader, Leslie C. Lilly, Felix Aberer, Tina Poettler, Don Johns, MICHAEL E. TRAUTMANN, JAY L. WARNER, Thomas Rudolf Pieber · 2018 · Diabetic Medicine
Efficacy and safety of insulin glargine/lixisenatide (iGlarLixi) fixed-ratio combination in older adults with type 2 diabetes
Yehuda Handelsman, Christina Chovanes, TERRY A. DEX, Francesco Giorgino, NEIL SKOLNIK, Elisabeth Souhami, William Stager, Elisabeth Niemoeller, Juan P. Frías · 2018 · Journal of Diabetes and its Complications
Psychological Outcomes in Children and Early Adolescents With Type 1 Diabetes Following Pediatric Diabetes Summer Camp: A 3-Month Follow-Up Study
Alda Troncone, Antonietta Chianese, Crescenzo Cascella, Angela Zanfardino, Dario Iafusco · 2021 · Frontiers in Pediatrics
Use of Connected Pen as a Diagnostic Tool to Evaluate Missed Bolus Dosing Behavior in People with Type 1 and Type 2 Diabetes
Stephanie Edwards, Xuanyao He, Wenjie Wang, Jiat Ling Poon, Eric S. Meadows, David A. Price, Jennal L. Johnson, Howard A. Wolpert, William H. Polonsky · 2021 · Diabetes Technology & Therapeutics
Relevance of Adalimumab Product Attributes to Patient Experience in the Biosimilar Era: A Narrative Review
Jessica Ravikoff Allegretti, Jessica H. Brady, A.M. Wicker, Mark Latymer, Alvin F. Wells · 2024 · Advances in Therapy
The Clinical and Economic Impact of the V-Go® Disposable Insulin Delivery Device for Insulin Delivery in Patients with Poorly Controlled Diabetes at High Risk
Rosemarie Lajara, CARLA C. NIKKEL, Scott Abbott · 2016 · Drugs - Real World Outcomes
Mode of administration of dulaglutide: implications for treatment adherence
Ambika Pinakini Amblee · 2016 · Patient Preference and Adherence
Attributes Influencing Insulin Pen Preference Among Caregivers and Patients With Diabetes Who Require Greater Than 20 Units of Mealtime Insulin
Tao Wang, Kenneth A. Conrad, Kate Van Brunt, Tina M. Rees · 2016 · Journal of Diabetes Science and Technology
Combination of saxagliptin and metformin is effective as initial therapy in new-onset type 2 diabetes mellitus with severe hyperglycemia
Amblee, Ambika, Lious, Daniel, Fogelfeld, Leon · 2016 · The Journal of Clinical Endocrinology & Metabolism
Improving the treatment experience for patients with type 2 diabetes: Role of the nurse practitioner
Tom Bartol · 2012 · Journal of the American Academy of Nurse Practitioners
Healthcare professional and patient perceptions of a new prefilled insulin pen versus vial and syringe
Rosemarie Lajara, German Guerrero, Jerome E. Thurman · 2012 · Expert Opinion on Drug Delivery
The co‐formulation of insulin degludec and insulin aspart lowers fasting plasma glucose and rates of confirmed and nocturnal hypoglycaemia, independent of baseline glycated haemoglobin levels, disease duration or body mass index: A pooled meta‐analysis of phase III studies in patients with type 2 diabetes
Martin Haluzı́k, Greg Fulcher, Thomas Rudolf Pieber, Lars Bardtrum, Deniz Tutkunkardas, Helena W. Rodbard · 2018 · Diabetes Obesity and Metabolism
Insulin degludec/liraglutide: innovation-driven combination for advancement in diabetes therapy
Ajay Kumar · 2014 · Expert Opinion on Biological Therapy
Comparison of Combined Tofogliflozin and Glargine, Tofogliflozin Added to Insulin, and Insulin Dose-Increase Therapy in Uncontrolled Type 2 Diabetes
Katsunori Suzuki, Yurie Mitsuma, Takaaki Sato, 匠安楽, Mariko Hatta · 2016 · Journal of Clinical Medicine Research
Barrier Factors of Adherence to Dupilumab Self-Injection for Severe Allergic Disease: A Non-Interventional Open-Label Study
Kei Hosoya, Taro Komachi, Katsunori Masaki, Isao Suzaki, Hidehisa Saeki, Naoko Kanda, Makoto Nozaki, Yosuke Kamide, Yoshinori Matsuwaki, Yoshiki Kobayashi et al. · 2023 · Patient Preference and Adherence
Formulation and Evaluation of Insulin-Loaded Sodium-Alginate Microparticles for Oral Administration
Ildikó Bácskay, Boglárka Papp, Péter Pártos, István Budai, Ágota Pető, Pálma Siposné Fehér, Zoltán Ujhelyi, Dóra Kósa · 2023 · Pharmaceutics
The Current and Future Role of Insulin Therapy in the Management of Type 2 Diabetes: A Narrative Review
Janet B. McGill, Irl B. Hirsch, Christopher G. Parkin, Grazia Aleppo, Carol Joan Levy, James R. Gavin · 2024 · Diabetes Therapy
Pharmacokinetic and prandial pharmacodynamic properties of insulin degludec/insulin aspart in children, adolescents, and adults with type 1 diabetes
Torben Biester, Thomas Danne, S Bläsig, K Remus, Bärbel Aschemeier, Olga Kordonouri, Lars Bardtrum, Hanne L. Haahr · 2016 · Pediatric Diabetes
US ethnic group differences in self-management in the 2nd diabetes attitudes, wishes and needs (DAWN2) study
Mark F. Peyrot, Leonard E. Egede, Martha M. Funnell, William C. Hsu, Laurie Ruggiero, Linda M. Siminerio, Heather L. Stuckey · 2018 · Journal of Diabetes and its Complications
When insulin degludec enhances quality of life in patients with type 2 diabetes: a qualitative investigation
James Weatherall, William H. Polonsky, Sally Lanar, Naomi B. Knoble, Jonas Håkan‐Bloch, Elisabeth Constam, Athena Philis‐Tsimikas, Alexia Marrel · 2018 · Health and Quality of Life Outcomes
Comparing Patch vs Pen Bolus Insulin Delivery in Type 2 Diabetes Using Continuous Glucose Monitoring Metrics and Profiles
Richard M. Bergenstal, Mary Lynn Johnson, Vanita R. Aroda, Ronald Brazg, Darlene M. Dreon, Juan P. Frías, Davida F. Kruger, Mark E. Molitch, Deborah M. Mullen, Mark F. Peyrot et al. · 2021 · Journal of Diabetes Science and Technology